September 6, 2024 – BD introduced that it has accomplished the acquisition of Edwards Lifesciences’ Crucial Care product group, which will likely be renamed BD Superior Affected person Monitoring. BD Superior Affected person Monitoring is a worldwide chief in superior monitoring options that expands BD’s portfolio of sensible related care options with its rising set of main monitoring applied sciences, superior AI-driven scientific resolution instruments, and strong innovation pipeline.

BD Superior Affected person Monitoring applied sciences are sometimes used concurrently with the BD Alaris™ Infusion System within the working room or intensive care unit. The mixture of BD’s new superior monitoring and present infusion platforms presents future innovation alternatives for closed-loop hemodynamic monitoring and IV fluid and drug administration by integrating mixed enterprise datasets and interoperability capabilities.

Extra data